Study on influencing factors on heparin reactivity-Reference-Cited by-同舟云学术

Study on influencing factors on heparin reactivity

Published:2020 Issue:2 Volume:47 Page:115-121
ISSN:0912-2664
Container-title:Japanese Journal of Extra-Corporeal Technology
language:en
Short-container-title:JJECT

Author:

Yamashiro Tomoaki¹,Hibiya Makoto,Kojima Kotone¹,Shimizu Kota¹,Fujiura Takuya¹,Takeuchi Ryo¹,Takagi Yasushi

Affiliation:

1. Department of Clinical Engineering Management, Fujita Health University Hospital

Publisher

The Japanese Society of Extra-Corporeal Technology in Medicine

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jject/47/2/47_115/_pdf

Reference17 articles.

1. 1) Shore-Lesserson L, Baker RA, Hammon J, et al.: STS/SCA/AmSECT Clinical Practice Guidelines: anticoagulation during cardiopulmonary bypass. J Extra Corpor Technol, 50(1); 5-18, 2018.

2. 2) Finley A, Greenberg C: Heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg, 116(6); 1210-1222, 2013.

3. 3) Panicucci F, Sagripanti A, Lecchini L, et al.: Antithrombin III , heparin cofactor and antifactor Xa in relation to age, sex and pathological condition. Haemostasis, 9(5); 297-302, 1980.

4. 4) Hattersley PG: Activated coagulation time of whole blood. JAMA, 196(5); 436-440, 1966.

5. 5) Bull BS, Huse WM, Korpman RA, et al.: Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg, 69(5); 685-689, 1975.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contributing factors to heparin resistance during cardiopulmonary bypass;Journal of Artificial Organs;2024-02-17